| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 255 | 2021 |
| Virus-induced senescence is a driver and therapeutic target in COVID-19 S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ... Nature 599 (7884), 283-289, 2021 | 239 | 2021 |
| Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real‐world study A D’Alessio, CAM Fulgenzi, N Nishida, M Schönlein, J von Felden, ... Hepatology 76 (4), 1000-1012, 2022 | 147 | 2022 |
| Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer J Tintelnot, Y Xu, TR Lesker, M Schönlein, L Konczalla, AD Giannou, ... Nature 615 (7950), 168-174, 2023 | 124 | 2023 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 65 | 2022 |
| Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: results of the AB-real study CAM Fulgenzi, J Cheon, A D'Alessio, N Nishida, C Ang, TU Marron, L Wu, ... European Journal of Cancer 175, 204-213, 2022 | 54 | 2022 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 51 | 2022 |
| CD20-targeting immunotherapy promotes cellular senescence in B-cell lymphoma JHM Däbritz, Y Yu, M Milanovic, M Schönlein, MT Rosenfeldt, JR Dörr, ... Molecular cancer therapeutics 15 (5), 1074-1081, 2016 | 38 | 2016 |
| Post-vaccination anti-SARS-CoV-2-antibody response in patients with multiple myeloma correlates with low CD19+ B-lymphocyte count and anti-CD38 treatment S Ghandili, M Schönlein, M Lütgehetmann, J Schulze zur Wiesch, ... Cancers 13 (15), 3800, 2021 | 35 | 2021 |
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab YL Wu, CAM Fulgenzi, A D’Alessio, J Cheon, N Nishida, A Saeed, ... Cancers 14 (23), 5834, 2022 | 30 | 2022 |
| Improved clinical outcome of COVID‐19 in hematologic malignancy patients receiving a fourth dose of anti‐SARS‐CoV‐2 vaccine: an EPICOVIDEHA report J Salmanton‐García, F Marchesi, A Glenthøj, YM Bilgin, J Van Praet, ... Hemasphere 6 (11), e789, 2022 | 27 | 2022 |
| COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) F Marchesi, J Salmanton-García, Z Emarah, K Piukovics, M Nucci, ... Haematologica 108 (1), 22, 2023 | 22 | 2023 |
| Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry A Busca, J Salmanton-García, F Marchesi, F Farina, GC Seval, ... Frontiers in immunology 14, 1125030, 2023 | 19 | 2023 |
| Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry J Salmanton-García, F Marchesi, MG da Silva, F Farina, J Dávila-Valls, ... EClinicalMedicine 58, 2023 | 17 | 2023 |
| Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry F Marchesi, J Salmanton-García, C Buquicchio, F Itri, C Besson, ... Journal of Hematology & Oncology 16 (1), 32, 2023 | 16 | 2023 |
| Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma M Vithayathil, A D'Alessio, CAM Fulgenzi, N Nishida, M Schönlein, ... Liver International 42 (11), 2538-2547, 2022 | 16 | 2022 |
| Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey JA van Doesum, J Salmanton-García, F Marchesi, R Di Blasi, ... Blood Advances 7 (11), 2645-2655, 2023 | 15 | 2023 |
| Lymphocytopenia and anti-CD38 directed treatment impact the serological SARS-CoV-2 response after prime boost vaccination in patients with multiple myeloma S Ghandili, M Schönlein, C Wiessner, H Becher, M Lütgehetmann, ... Journal of Clinical Medicine 10 (23), 5499, 2021 | 12 | 2021 |
| Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma M Vithayathil, A D’Alessio, CAM Fulgenzi, N Nishida, M Schönlein, ... Hepatology international 17 (4), 904-914, 2023 | 11 | 2023 |
| B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA) MS Infante, J Salmanton-García, A Fernandez-Cruz, F Marchesi, O Jaksic, ... Frontiers in oncology 12, 992137, 2022 | 10 | 2022 |
